The next logical step would be a prospective, biomarker-stratified, randomised trial in patients with decompensated ALD with evidence of high systemic inflammation, enriched for high CRP/NLR and preserved albumin, with glutathione versus placebo on top of standard care, and with MELD-3 trajectory, CRP change and pragmatic clinical outcomes as endpoints
Schedule a 15 min tele-health appt
Medicamento a tu puerta
This delayed absorption, combined with the medications' known side effects, may increase the likelihood of nausea, vomiting, or abdominal discomfort
Our team is here to support you every step of the way, providing personalized care and expert advice
doi: 10.1186/s40529-014-0063-5 33 de Torres-ZabalaM.TrumanW.BennettM